期刊文献+

止咳定喘汤联合孟鲁司特在咳嗽变异性哮喘中的临床疗效 被引量:27

Clinical Efficacy of Zhike Dingchuan Decoction Combined with Montelukast in Cough Variant Asthma
下载PDF
导出
摘要 目的探讨止咳定喘汤联合孟鲁司特对咳嗽变异性哮喘患者炎症因子及气道反应性的影响,分析其临床疗效。方法咳嗽变异性哮喘患者120例,按随机数字表法将患者分为孟鲁司特钠咀嚼片治疗组40例,单独止咳定喘汤治疗组40例,止咳定喘汤联合孟鲁司特治疗组40例,连续治疗3个月,观察各组患者血清的白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子α(TNF-α)、血清IgE水平、肺功能指标、呼气一氧化氮(FeNO)、ACT评分和AQLQ评分变化。结果治疗后止咳定喘汤联合孟鲁司特治疗组的血清IL-1β、IL-6、TNF-α、IgE水平明显低于单独止咳定喘汤组和单独使用孟鲁司特组患者(P<0.05);止咳定喘汤联合孟鲁司特治疗组的肺功能指标FEV1、FEV1/FVC、FEV1%,FEV1改善率、FeNO、ACT评分、AQLQ评分明显优于单独止咳定喘汤组和单独使用孟鲁司特组患者(P<0.05)。结论止咳定喘汤联合孟鲁司特治疗咳嗽变异性哮喘可以有效缓解患者的炎症反应,增强免疫力,改善患者的肺功能,控制患者的哮喘,具有极大的临床应用价值。 Objective To investigate the effect of Zhike Dingchuan decoction combined with montelukast on inflammatory factors and airway responsiveness in patients with cough variant asthma,and to analyze its clinical efficacy.Methods 120 patients who met the CVA diagnostic criteria were selected as the research objects.And according to the random number table method,the patients were divided into experimental group who was treated with Zhike Dingchuan decoction combined with montelukast(n=40),control group 1 who was treated with montelukast sodium chewable tablet(n=40),and control group 2 who was treated with Zhike Dingchuan decoction(n=40).The treatments continued for 3 months and the serum IL-1β,IL-6,TNF-α,serum IgE levels,pulmonary function,FeNO,ACT,and AQLQ were monitored and compared.Results The serum levels of IL-1β,IL-6,TNF-α,and IgE in the experimental group were significantly lower than those in the treatment group of Zhike dingchuan decoction alone and montelukast alone(P<0.05),and the pulmonary function indexes FEV1,FEV1/FVC,FEV1%,FEV1 improvement rate,FeNO,ACT score,AQLQ score were significantly better in the experimental group than those in the control group 1 and 2,and the differences were statistically significant(P<0.05).Conclusion The treatment of cough variant asthma with Zhike Ding chuan decoction combined with montelukast could effectively relieve the inflammatory response,enhance the immunity,improve the lung function of the patients,and control the patient's asthma,which have great clinical application values.
作者 王红娟 郭红荣 张恩景 戴芹 徐建群 周利君 WANG Hongjuan;GUO Hongrong;ZHANG Enjing;DAI Qin;XU Jianqun;ZHOU Lijun(Department of Respiration,the Third Hospital of Wuhan,Wuhan 430074,China;Department of Clinical Pharmacy, the Third Hospital of Wuhan, Wuhan 430074, China)
出处 《医药导报》 CAS 北大核心 2020年第4期568-572,共5页 Herald of Medicine
基金 武汉市卫生计生委科研计划资助项目(WZ18E08)。
关键词 止咳定喘汤 孟鲁司特 哮喘 咳嗽变异性 炎症因子 气道反应性 Zhike Dingchuan decoction Montelukast Cough variant asthma Inflammatory factor Airway reactivity
  • 相关文献

参考文献3

二级参考文献33

共引文献2736

同被引文献283

引证文献27

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部